President Donald Trump listens as Dr. Moncef Slaoui, the former head of GlaxoSmithKlines vaccines division, speaks about coronavirus vaccine development in the Rose Garden of the White House on May 15, 2020. (Photo: Drew Angerer/Getty Images)
Aug 20, 2020
Rep. Katie Porter is demanding a "full, independent" inspector general investigation into whether President Donald Trump flouted longstanding ethics laws to put a former pharmaceutical executive with a slew of potential conflicts of interest in charge of the White House initiative tasked with developing a Covid-19 vaccine.
"By evading these longstanding laws, the administration is harming public trust in the vaccine effort."
--Rep. Katie Porter
In a letter Wednesday to the inspectors general of the Health and Human Services Department and the Office of Personnel Management, the California Democrat expressed alarm at "reports that President Trump is violating ethics laws and established procedures in order to place individuals at the helm of his administration's vaccine research and development efforts without subjecting them to standard requirements of government employees."
"Abiding by clear and longstanding ethics guidelines prevents distrust and confusion," Porter wrote. "By evading these longstanding laws, the administration is harming public trust in the vaccine effort. As such, I request that you conduct an investigation into Dr. Moncef Slaoui's employment as the co-leader of Operation Warp Speed, make recommendations on his government employment status, and provide a public record on the results."
\u201cThe Administration put Big Pharma executives at the helm of efforts to develop a COVID vaccine. But they\u2019re not required to let the public know if they\u2019d financially benefit from the vaccine that makes it into mass production. This deserves a full, independent investigation.\u201d— Rep. Katie Porter (@Rep. Katie Porter) 1597864088
Trump appointed Slaoui to help lead the $10 billion public-private coronavirus vaccine effort in May, prompting outcry from government watchdogs who said Slaoui's current investments in the pharmaceutical industry and past as an executive at healthcare giant GlaxoSmithKline should have disqualified him from serving in the role.
Last month, as Common Dreams reported, the HHS inspector general ruled that Slaoui does not have to disclose or sell off his investments in the pharmaceutical industry because the Trump administration classified him as a "volunteer contractor" rather than a federal employee.
"Dr. Slaoui has 'maintained that as a consultant, he is only offering advice and not making decisions,' but considering his leading role as one of two individuals in charge of Operation Warp Speed, this seems implausible," Porter wrote Wednesday. "Though Dr. Slaoui had said he would accept a payment of only $1 for his services, Politico reported [late last month] that the arrangement is covered through a $611,500 contract."
The California Democrat noted that former Pfizer executives William Erhardt and Rachel Harrigan are also covered by the contract, raising further concerns that Trump appointees are unethically profiteering off a taxpayer-funded initiative.
"This process must be transparent in order to instill confidence in the American people that this vaccine is safe and effective," Porter wrote. "Any sense that the leaders of Operation Warp Speed are working to serve their respective interests, rather than the public health and safety of the American people, threatens to undermine this objective."
Join Us: News for people demanding a better world
Common Dreams is powered by optimists who believe in the power of informed and engaged citizens to ignite and enact change to make the world a better place. We're hundreds of thousands strong, but every single supporter makes the difference. Your contribution supports this bold media model—free, independent, and dedicated to reporting the facts every day. Stand with us in the fight for economic equality, social justice, human rights, and a more sustainable future. As a people-powered nonprofit news outlet, we cover the issues the corporate media never will. |
Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.
Rep. Katie Porter is demanding a "full, independent" inspector general investigation into whether President Donald Trump flouted longstanding ethics laws to put a former pharmaceutical executive with a slew of potential conflicts of interest in charge of the White House initiative tasked with developing a Covid-19 vaccine.
"By evading these longstanding laws, the administration is harming public trust in the vaccine effort."
--Rep. Katie Porter
In a letter Wednesday to the inspectors general of the Health and Human Services Department and the Office of Personnel Management, the California Democrat expressed alarm at "reports that President Trump is violating ethics laws and established procedures in order to place individuals at the helm of his administration's vaccine research and development efforts without subjecting them to standard requirements of government employees."
"Abiding by clear and longstanding ethics guidelines prevents distrust and confusion," Porter wrote. "By evading these longstanding laws, the administration is harming public trust in the vaccine effort. As such, I request that you conduct an investigation into Dr. Moncef Slaoui's employment as the co-leader of Operation Warp Speed, make recommendations on his government employment status, and provide a public record on the results."
\u201cThe Administration put Big Pharma executives at the helm of efforts to develop a COVID vaccine. But they\u2019re not required to let the public know if they\u2019d financially benefit from the vaccine that makes it into mass production. This deserves a full, independent investigation.\u201d— Rep. Katie Porter (@Rep. Katie Porter) 1597864088
Trump appointed Slaoui to help lead the $10 billion public-private coronavirus vaccine effort in May, prompting outcry from government watchdogs who said Slaoui's current investments in the pharmaceutical industry and past as an executive at healthcare giant GlaxoSmithKline should have disqualified him from serving in the role.
Last month, as Common Dreams reported, the HHS inspector general ruled that Slaoui does not have to disclose or sell off his investments in the pharmaceutical industry because the Trump administration classified him as a "volunteer contractor" rather than a federal employee.
"Dr. Slaoui has 'maintained that as a consultant, he is only offering advice and not making decisions,' but considering his leading role as one of two individuals in charge of Operation Warp Speed, this seems implausible," Porter wrote Wednesday. "Though Dr. Slaoui had said he would accept a payment of only $1 for his services, Politico reported [late last month] that the arrangement is covered through a $611,500 contract."
The California Democrat noted that former Pfizer executives William Erhardt and Rachel Harrigan are also covered by the contract, raising further concerns that Trump appointees are unethically profiteering off a taxpayer-funded initiative.
"This process must be transparent in order to instill confidence in the American people that this vaccine is safe and effective," Porter wrote. "Any sense that the leaders of Operation Warp Speed are working to serve their respective interests, rather than the public health and safety of the American people, threatens to undermine this objective."
Rep. Katie Porter is demanding a "full, independent" inspector general investigation into whether President Donald Trump flouted longstanding ethics laws to put a former pharmaceutical executive with a slew of potential conflicts of interest in charge of the White House initiative tasked with developing a Covid-19 vaccine.
"By evading these longstanding laws, the administration is harming public trust in the vaccine effort."
--Rep. Katie Porter
In a letter Wednesday to the inspectors general of the Health and Human Services Department and the Office of Personnel Management, the California Democrat expressed alarm at "reports that President Trump is violating ethics laws and established procedures in order to place individuals at the helm of his administration's vaccine research and development efforts without subjecting them to standard requirements of government employees."
"Abiding by clear and longstanding ethics guidelines prevents distrust and confusion," Porter wrote. "By evading these longstanding laws, the administration is harming public trust in the vaccine effort. As such, I request that you conduct an investigation into Dr. Moncef Slaoui's employment as the co-leader of Operation Warp Speed, make recommendations on his government employment status, and provide a public record on the results."
\u201cThe Administration put Big Pharma executives at the helm of efforts to develop a COVID vaccine. But they\u2019re not required to let the public know if they\u2019d financially benefit from the vaccine that makes it into mass production. This deserves a full, independent investigation.\u201d— Rep. Katie Porter (@Rep. Katie Porter) 1597864088
Trump appointed Slaoui to help lead the $10 billion public-private coronavirus vaccine effort in May, prompting outcry from government watchdogs who said Slaoui's current investments in the pharmaceutical industry and past as an executive at healthcare giant GlaxoSmithKline should have disqualified him from serving in the role.
Last month, as Common Dreams reported, the HHS inspector general ruled that Slaoui does not have to disclose or sell off his investments in the pharmaceutical industry because the Trump administration classified him as a "volunteer contractor" rather than a federal employee.
"Dr. Slaoui has 'maintained that as a consultant, he is only offering advice and not making decisions,' but considering his leading role as one of two individuals in charge of Operation Warp Speed, this seems implausible," Porter wrote Wednesday. "Though Dr. Slaoui had said he would accept a payment of only $1 for his services, Politico reported [late last month] that the arrangement is covered through a $611,500 contract."
The California Democrat noted that former Pfizer executives William Erhardt and Rachel Harrigan are also covered by the contract, raising further concerns that Trump appointees are unethically profiteering off a taxpayer-funded initiative.
"This process must be transparent in order to instill confidence in the American people that this vaccine is safe and effective," Porter wrote. "Any sense that the leaders of Operation Warp Speed are working to serve their respective interests, rather than the public health and safety of the American people, threatens to undermine this objective."
We've had enough. The 1% own and operate the corporate media. They are doing everything they can to defend the status quo, squash dissent and protect the wealthy and the powerful. The Common Dreams media model is different. We cover the news that matters to the 99%. Our mission? To inform. To inspire. To ignite change for the common good. How? Nonprofit. Independent. Reader-supported. Free to read. Free to republish. Free to share. With no advertising. No paywalls. No selling of your data. Thousands of small donations fund our newsroom and allow us to continue publishing. Can you chip in? We can't do it without you. Thank you.